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TECHNICAL NOTE
Role of fibrinogen in the glomerular permeability of the
perfused, isolated dog kidney
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Departments of Medical Biochemistry and Internal Medicine, University of Calgary, Calgary, Alberta, Canada
A technique commonly used in the preservation of human
kidneys awaiting transplantation is pulsatile perfusion with a
solution that contains a commercially derived protein fraction
obtained from human plasma [1]. It has been shown that
perfusion of dog kidneys with such a solution results in the
appearance of considerable amounts of protein in the urine [2,
31. On investigation, it was observed that the protein compo-
nent of the perfusate consisted of albumin, and alpha 1 and 2
globulins, but did not contain any fibrinogen or gamma globulin.
Preliminary studies revealed that when fibrinogen was added to
the perfusate, the proteinuria appeared to diminish. The fact
that this was associated with an increase in glomerular filtration
rate (GFR) lead us to examine more closely the mechanism by
which fibrinogen exerts its effect, on the assumption that such a
study might contribute to an understanding of the mechanism
by which proteins normally are prevented from passing from
the plasma into the glomerular filtrate. As well, the effect of
fibrinogen on the functional integrity of kidneys which are to be
used for transplantation was of additional interest.
The human plasma fraction used in the perfusion fluid was
either obtained commercially (Cutter Diagnostics, Missisauga,
Ontario, Canada) or was prepared from plasma obtained from
patients undergoing plasmapheresis. Fifty milliliters (200,000
KIU/ml) of the plasmin inhibitor Trasylol were added to each
liter of this plasma. The plasma was then incubated for 1 hr at
room temperature with 90 g of solid barium sulphate and 5.3 g
of magnesium sulphate to absorb the thrombin [41. Following
centrifugation, the absorption step was repeated on the super-
natant twice more. A 50% solution of polyethylene glycol (PEG
6000) was then added to the supernatant to make it 10% weight
per volume with respect to PEG, and the precipitate was
removed by centrifugation at x l0,000g for 30 mm at room
temperature. (The PEG was utilized to precipitate albumin,
alpha I and alpha 2 globulin.) The pH of the supernatant was
adjusted to 5.0 with 0.1 N HC1 and the precipitate (plasmonate)
was dissolved in 0.45 M sodium acetate buffer, pH 7.0, contain-
ing 85 mmoles sodium chloride and 40 mm acetyltryptophan, to
give a protein concentration of 4.5 g/dl. To this solution was
added 2.5 g dextrose, 250,000 U of potassium penicillin 0, 62.5
mg of methylprednisolone, 2,500 U heparin, 149 mg potassium
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chloride, 50 U of crystalline insulin, 12.5 g of human serum
albumin, 40 mg of furosamide, 500 mg magnesium sulphate, and
mannitol to give a final osmolarity of 315 to 330 mOsm. The pH
of the perfusate was then adjusted to 7.0 with solid sodium
bicarbonate and stored at +4°C until it was used for perfusion.
Pure human fibrinogen was prepared according to the method of
Masri, Masri, and Boyd [51.
To obtain dextrans of low molecular weights, a large molecu-
lar weight dextran (500,000) was hydrolyzed according to the
method of Chang et al [6] as follows:
One gram of Dextran sulphate (Pharmacia) or Diethyl
Aminoethyl Dextran (DEAED) was added to 18 ml of distilled
water and 2 ml in HC 1; the solution was then incubated at 100°C
for 40 mm. The solution was applied to a S-200 superfine
column (5 cm x 50 cm) (425 ml), calibrated with ferritin (Kay
0.06), catalase (Kay 0.123), and albumin (Kay 0.3). Fractions
that corresponded to the desired Kay range were collected and
concentrated using an ultrafiltration cell (Amicon, Lexington,
Massachusetts, USA) fitted with an XM 30 membrane (Sigma
Chemical Co., St. Louis, Missouri, USA). Dextran concentra-
tions were measured according to the method of Chang et al [7].
Kidneys of 37 dogs were used, nine of which served as
controls (no fibrinogen added). They were removed and placed
in an ice slush. After flushing the kidneys with 500 ml of Collins
solution by gravity feed, the kidneys were then attached to a
kidney pump (Waters MOX-100) and perfused at 4°C in the
usual manner [2, 3]. The perfusion pressure was maintained at
60 mm Hg and the pulse rate at 60/mm. Plasma flow was
monitored throughout. The kidneys were then used in the
following studies. Kidneys from seven dogs were perfused in
pairs for 4 hr with inulin (0.03 g/dl) added. After 2 hr, 0.3 g/dl of
fibrinogen was added to the perfusate. Urine samples were
collected every 30 mm from each kidney and a determination
was made of the volume, protein content, electrophoretic
profile, and activity of the enzymes lactate dehydrogenase
(LDH), creatine phosphokinase (CPK), and alkaline phospha-
tase (ALP). GFR was also calculated. Kidneys from 21 other
dogs were perfused in a similar fashion, except for the addition
of dextrans (0.1 g/dl) of different molecular weights and charges
to the perfusate. These kidneys were perfused without fi-
brinogen for 2 hr and with fibrinogen for an additional 2-hr
period. Urine samples were collected every 30 mm for 4 hr. The
volume of each of the urine samples was measured, and the
dextran content of both urine and perfusate was determined.
Renal plasma flow was measured using an electromagnetic
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Fig. 1. Urinary protein excretion over 4 hr for dog kidneys maintained
on a kidney pump, with (•) or without (0) fibrinogen in the perfusate
(values are expressed as per 100 g of kidney; mean SD). Symbol:
fibrinogen concentration.
flow meter (Narco Biosystems Model RT-400). GFR was deter-
mined from the clearance of inulin. Plasma and urine inulin
concentrations were determined by the diphenylamine method
[81. Urine protein concentrations were measured using the
method of Lowry et al [9] and a turbidimetric method [101.
The protein composition of the commercially obtained
plasmonate and that prepared from plasma, and the protein
composition of urine samples were determined by cellulose
acetate electrophoresis using a microzone electrophoresis
apparatus (Beckman Instruments, Inc., Fullerton, Califor-
nia, USA) at pH 8.6. Enzyme activity was measured using
an automated procedure (Gemini II Electronucleonics
instrument).
For electron microscopy kidney cortex cubes of 1 mm3 were
fixed in buffered glutaraldehyde and imbedded in Epon. Thin
sections containing glomeruli were stained with uranyl acetate
and lead citrate and examined using a transmission electron
microscope (Philips 300).
For immunofluorescence studies, specimens were cut using a
cryostat and mounted on microscope slides, washed in PBS
buffer, and fixed with ethanol/ether (1:1). All sections were
incubated for 30 mm with fluorescent-labeled goat anti-human
fibrinogen (Cappal).
Statistical analysis of the data was calculated using the
Student's paired t test. Values are expressed per 100 grams of
kidney weight.
Perfusion of dog kidneys with perfu sate resulted in significant
proteinuria. However, when fibrinogen was added to the per-
fusate, there was a progressive reduction in the amount of
protein appearing in the urine (P < 0.001 after 120 mm; Fig. 1).
There was also a marked decrease in the urinary level of
LDH (1500 to 50 lU/liter; P < 0.001 after 120 mi, CPK (120 to
40 lU/liter; P < 0.001 after 120 mm), and alkaline phosphatase
(85 to 5 lU/liter; P < 0.001 after 120 mm). Urine output from the
perfused kidneys increased in the presence of fibrinogen, and
this was associated with an increase in the renal plasma flow
rate from 1.5 ml/min/g of kidney to 1.95 ml/min/g of kidney and
an increase in the GFR (P < 0.001 after 120 mm; Fig. 2).
For neutral dextrans there was no significant difference in
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Fig. 2. Changes in the renal plasma flow (RPF), upper panel, glomeru-
lar filtration rate (GFR), lower panel, in perfused dog kidneys in the
presence and absence of fibrinogen in the perfusate (Mean SD).
Symbols: A, before fibrinogen added; , fibrinogen added; 0, con-
trol—no fibrinogen added; ---, fibrinogen concentration; —, renal
plasma flow.
fractional excretion before and after fibrinogen. With positively
charged dextrans, there was a significant increase in the frac-
tional clearance for dextrans larger than a protein of a Kay
value of 0.26 and smaller than 0.30 when fibrinogen was present
in the perfusate. However, for negatively charged dextrans
there was a considerable decrease in their fractional clearance
over the entire Kay range that was investigated (P < 0.01
between 0.36 and 0.46), (P < 0.001 between 0.36 and 0.2), (P <
0.01 when Kay < 0.2, Fig. 3).
The glomerular filtration rate was increased significantly by
fibrinogen in the presence of neutral and negatively charged
dextrans. Renal plasma flow rate for neutral and negative
dextrans was increased (Table 1). Electron microscopy studies
did not reveal detectable structural abnormalities in the
glomeruli and tubules of the kidneys perfused with the perfuate
containing fibrinogen. Immunofluorescent studies for the detec-
tion of fibrinogen on the glomerular capillary wall were nega-
tive.
The finding of considerable quantities of protein in the urine
of dog kidneys perfused with perfusate lacking fibrinogen
suggests that, under the conditions used, the effects of charge
repulsion and pore size restriction are insufficient to prevent
negatively charged substances, such as albumin, from passing
through the negatively charged glomerular basement membrane
and the slit-pore diaphragm into the urinary space. This was
also observed by other investigators using similar perfusates [2,
31. Because the addition of physiologic quantities of fibrinogen
to the perfusate resulted in a marked reduction in proteinuria,
this would indicate that this plasma protein is involved in some
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GFR RPF
Without With Without With
fibrinogen fibrinogen
ml/minIlOO ga mlIminIlOO ga
Neutral dextran 6.8 0.5 7.8 06b 160 4 170 5c
Negative dextran 8.1 0.8 12.8 0.6c 170 5 220 7C
Positive dextran 6.6 0.6 6.0 0.6 150 6 130 6
additional mechanism that limits the passage of protein across
the glomerular filter.
Due to its large molecular weight, its large size (over 75 nm)
[11], its net negative charge (p1 5.5), and the negative results
obtained with immunofluorescence, fibrinogen would not be
expected to bind or to traverse the glomerular wall to any great
extent. However, it would be expected to reach the
subendothelium where it could form a concentration polariza-
tion layer in the relatively unstirred zone beneath the endothe-
hum. This layer could then restrict the access of negatively
charged plasma proteins, such as albumin, to the glomerular
basement membrane. Deen, Robertson, and Brenner [12] who
postulated the existence of such a layer indicated that it would
be expected to consist of plasma proteins whose most important
characteristic would be a sufficiently large size to render them
unable to penetrate the GBM. However, the clearance results
would indicate that this layer would be more effective in
preventing the loss of negatively charged proteins such as
albumin if it is made of large molecules that are negatively
charged as well. Furthermore, since the urinary protein loss
occurred with kidneys perfused with plasmonate containing all
the plasma proteins with the exception of fibrinogen and the
gamma globulin fractions and since gamma globulin failed to
cause any major reduction in proteinuria when added to the
perfusate [13], it would appear that fibrinogen is the most
important constituent of this concentration polarization layer.
The observation by Westberg and Michael [14] that col-
lagenase extracts of glomerular basement membrane contain a
disproportionately large amount of fibrinogen may indicate that
fibrinogen localizes in the region of the glomerular basement
membrane.
The filtration rate and plasma flow of the kidneys perfused
were low. Such low values were consistent with the values
obtained from isolated kidneys perfused with similar perfusates
under similar conditions [15—18]. Inclusion of fibrinogen in the
perfusion fluid resulted in improved kidney function, as evi—
denced by an increased renal plasma flow rate and an increased
GFR. This was associated with a decrease in the urinary
enzyme levels. Since CPK, with a molecular weight of 80,000
was reduced in the urine to a degree similar to LDH, with a
molecular weight of 150,000, it is probable that the decrease in
urinary enzyme levels represents a reduction in the release of
enzymes from the renal parenchyma rather than a decrease in
the glomerular filtration of these proteins. This finding is
consistent with a decrease in cellular damage. Whether the
addition of fibrinogen to the perfusate is beneficial in the
preservation of kidneys awaiting transplantation will require
further investigation.
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